The Uremic Toxin p-Cresyl Sulfate Is a New Predictor of Major Adverse Cardiovascular Events in Patients with ST-Elevation Myocardial Infarction
Toxins · 20.12.2025 · 18 (1) · 4
DOI: 10.3390/toxins18010004 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Toxins, online erschienen am 20.12.2025. Verfasst von Laure-Anne Raillon und 4 weiteren Autor:innen. Beteiligte Einrichtung: CarMeN Lab, INSERM U1060, INRAe U1397, Université Claude Bernard Lyon-1, 69500 Bron, France. Hauptthemen laut MEDLINE: Cresols, ST Elevation Myocardial Infarction, Sulfuric Acid Esters, Uremic Toxins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RHU MARVELOUS.
Abstract (Originalsprache)
ST-elevation myocardial infarction (STEMI) remains a major health concern despite advances in care. Indoxyl sulfate (IS) and p-cresyl-sulfate (p-CS) are gut-derived uremic toxins linked to higher morbidity and mortality in patients with chronic kidney disease (CKD). IS has been identified as an independent predictor of major adverse cardiovascular events (MACE) after STEMI, but data on p-CS are lacking. This study assessed the predictive value of IS and p-CS in STEMI patients with preserved renal function (cohort # NCT03070496). Plasma IS and p-CS were measured in 260 patients with STEMI who underwent primary coronary angiography. Samples collected 4 h after inclusion were analyzed using ultra-performance liquid chromatography with fluorescence detection. Optimal cut-offs were determined by the Youden index, and associations with MACE were evaluated by log-rank tests and Cox regression. Among 234 analyzed patients, 11.5% experienced MACE within one year. IS and p-CS levels were higher in the MACE group (IS: 3.14 vs. 2.19 µmol/L, p < 0.05; p-CS: 6.76 vs. 2.70 µmol/L, p < 0.01). Elevated p-CS independently predicted MACE (HR 3.79, 95% CI 1.29–11.17, p < 0.05), whereas IS lost significance after adjusting for kidney function. In STEMI patients, plasma p-CS is a stronger independent predictor of MACE than IS, highlighting its potential role in the gut–heart axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CarMeN Lab, INSERM U1060, INRAe U1397, Université Claude Bernard Lyon-1, 69500 Bron, France.
- Hospices Civils de Lyon, Service de Néphrologie, Hôpital E Herriot, 69003 Lyon, France.
- Hospices Civils de Lyon, Unité de Soins Intensifs Cardiologiques (USIC), Hôpital Louis Pradel, 69500 Bron, France.
- Nephrology Section, Department of Internal Medicine and Pediatrics, Ghent University, 9000 Gent, Belgium.
ORCID-Profile: Laure-Anne Raillon, Thomas Bochaton, Griet Glorieux, Fitsum Guebre-Egziabher, Christophe Olivier Soulage
Förderung
- RHU MARVELOUS
Zitieren
APA
Raillon, L. A., Bochaton, T., Glorieux, G., Guebre-Egziabher, F., & Soulage, C. O. (2025). The Uremic Toxin p-Cresyl Sulfate Is a New Predictor of Major Adverse Cardiovascular Events in Patients with ST-Elevation Myocardial Infarction. Toxins, 18(1), 4. https://doi.org/10.3390/toxins18010004
Vancouver
Raillon LA, Bochaton T, Glorieux G, Guebre-Egziabher F, Soulage CO. The Uremic Toxin p-Cresyl Sulfate Is a New Predictor of Major Adverse Cardiovascular Events in Patients with ST-Elevation Myocardial Infarction. Toxins. 2025;18(1):4. doi:10.3390/toxins18010004
BibTeX
@article{Raillon2025,
author = {Raillon, Laure-Anne and Bochaton, Thomas and Glorieux, Griet and Guebre-Egziabher, Fitsum and Soulage, Christophe Olivier},
title = {The Uremic Toxin p-Cresyl Sulfate Is a New Predictor of Major Adverse Cardiovascular Events in Patients with ST-Elevation Myocardial Infarction},
journal = {Toxins},
year = {2025},
volume = {18},
number = {1},
pages = {4},
doi = {10.3390/toxins18010004}
}
EUVIMED